Walleye Trading’s Regenxbio RGNX Stock Holding History

Walleye Trading’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,300	Closed	-$122K	–	4523
2020 Q2	$122K	Sell	3,300 -10,600	-76%	-$395K	﹤0.01%	3398
2020 Q1	$450K	Buy	13,900 +4,900	+54%	+$204K	﹤0.01%	1958
2019 Q4	$369K	Buy	+9,000	New	+$356K	﹤0.01%	2664
2018 Q4	–	Sell	-2,600	Closed	-$196K	–	5192
2018 Q3	$196K	Sell	2,600 -14,900	-85%	-$1.07M	﹤0.01%	3775
2018 Q2	$1.26M	Buy	+17,500	New	+$836K	0.01%	1850

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Walleye Trading's RGNX Position: Q2 2020 in Review

Walleye Trading sold out of Regenxbio (RGNX) in Q2 2020, closing a stake of 319 shares — an estimated $11.9K sold.

Walleye Trading first reported a position in RGNX in Q3 2018 and held it in 2 quarters. The position peaked at $67K in Q3 2018. 179 funds tracked by Wall St. Rank hold RGNX as of Q2 2020.

Walleye Trading reported no remaining Regenxbio position as of Q2 2020 after selling out during the quarter.
Walleye Trading sold 319 Regenxbio shares in Q2 2020, an estimated $11.9K.
Walleye Trading first reported a position in Regenxbio in Q3 2018 and held it in 2 quarters.
Walleye Trading's Regenxbio position peaked at $67K in Q3 2018.
179 funds tracked by Wall St. Rank held Regenxbio as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.